This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: M2556v1 15/2/130    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Fridsma, D. B. Articles by Mead, C. N. PubMed PubMed Citation Articles by Fridsma, D. B. Articles by Mead, C. N.

The BRIDG Project: A Technical Report

^a Department of Biomedical Informatics, Arizona State University, Phoenix, AZ
^b Clinical Data Interchange Standards Consortium, Washington DC
^c ScenPro Inc., Washington DC
^d Booz Allen Hamilton/National Cancer Institute, Washington DC.

^_* Correspondence: Douglas B Fridsma, MD, PhD, Department of Biomedical Informatics, Arizona State University, Arizona Biomedical Collaborative, 425 N. 5th Street, Phoenix, AZ 85004-2157 (Email: fridsma{at}asu.edu).

Received for publication: 07/13/07; accepted for publication: 12/10/07.

Objectives: The Biomedical Research Integrated Domain Group (BRIDG) project is a collaborative initiative between the National Cancer Institute (NCI), the Clinical Data Interchange Standards Consortium (CDISC), the Regulated Clinical Research Information Management Technical Committee (RCRIM TC) of Health Level 7 (HL7), and the Food and Drug Administration (FDA) to develop a model of the shared understanding of the semantics of clinical research.

Design: The BRIDG project is based on open-source collaborative principles and an implementation-independent, use-case driven approach to model development. In the BRIDG model, declarative and procedural knowledge are represented using the Unified Modeling Language (UML) class, activity and state diagrams.

Measurements: The BRIDG model currently contains harmonized semantics from four project use cases: the caXchange project and the patient study calendar project from caBIG^TM; the standard data tabular model (SDTM) from CDISC; and the regulated products submission model (RPS) from HL7. Scalable harmonization processes have been developed to expand the model with content from additional use cases.

Results: The first official release of the BRIDG model was published in June 2007. Use of the BRIDG model by the NCI has supported the rapid development of semantic interoperability across applications within the caBIG^TM program.

Conclusions: The BRIDG project has brought together different standards communities to clarify the semantics of clinical research across pharmaceutical, regulatory, and research organizations. Currently, the NCI uses the BRIDG model to support interoperable application development in the caBIG^TM, and CDISC and HL7 are using the BRIDG model to support standards development.